Showing results (61-70 of 135) with videos related to
Sort By:
Pageof 14
Journal of Proteomics|May 15, 2012
Immunoassay-based proteome profiling of 24 pancreatic cancer cell linesMohamed Saiel Saeed Alhamdani, Mahmoud Youns, Malte Buchholz, et al.Translational Oncology|April 2, 2013
LCN2 and TIMP1 as Potential Serum Markers for the Early Detection of Familial Pancreatic CancerEmily P Slater, Volker Fendrich, Konstantin Strauch, et al.Journal of Molecular Medicine (Berlin, Germany)|November 29, 2011
Differentiation of multiple types of pancreatico-biliary tumors by molecular analysis of clinical specimensThomas M Gress, Hans A Kestler, Ludwig Lausser, et al.United European Gastroenterology Journal|July 20, 2024
Pancreatic cancer screening is effective in individuals at risk with predisposing germline gene variants, but not in gene variant-negative familial pancreatic cancer familiesElisabeth Maurer, Bettina Lehman, Elvira Matthäi, et al.BMC Bioinformatics|January 31, 2008
VennMaster: area-proportional Euler diagrams for functional GO analysis of microarraysHans A Kestler, André Müller, Johann M Kraus, et al.Digestion|March 25, 2009
Selective internal radiotherapy with Yttrium-90 microspheres for hepatic metastatic neuroendocrine tumors: a prospective single center studyMarc Kalinowski, Miriam Dressler, Alexander König, et al.The Journal of Biological Chemistry|June 3, 2010
Sequential activation of NFAT and c-Myc transcription factors mediates the TGF-beta switch from a suppressor to a promoter of cancer cell proliferationGarima Singh, Shiv K Singh, Alexander König, et al.Cellular and Molecular Life Sciences : CMLS|October 15, 2018
DYRK1B regulates Hedgehog-induced microtubule acetylationRajeev Singh, Philipp Simon Holz, Katrin Roth, et al.Oncotarget|October 15, 2017
The deubiquitinating enzyme USP5 promotes pancreatic cancer via modulating cell cycle regulatorsBrajesh P Kaistha, Anja Krattenmacher, Johannes Fredebohm, et al.Oncotarget|January 13, 2016
A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancersSandra Hocke, Yang Guo, Albert Job, et al.Pageof 14